|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 玻璃纤维/木塑混杂复合材料及其协同增强效应显示文摘将固体废弃物中的高密度聚乙烯(HDPE)回收后与废弃的木纤维以及短切玻璃纤维进行复合,成功地制备出混杂型木塑复合材料。研究结果表明,采用长径比较大的L型玻璃纤维增强时,木塑复合材料的弯曲强度、弯曲模量以及冲击强度同时得到提高,而采用长径比较小的玻璃纤维增强时,弯曲性能和冲击强度均呈现下降趋势。玻璃纤维增强木塑复合材料的主要破坏模式为玻璃纤维的拔出、玻璃纤维断裂、界面脱粘等。在玻璃纤维/木纤维/HDPE混杂体系中由于组元之间的协同增强作用,形成了特殊的三维网络结构,木塑复合材料的力学性能得到显著改善。 | 崔益华 Noruziaan Bahman Lee Stephen Chang Moe 陶杰 | 2006 | 高分子材料科学与工程2006，22，3： | 37 |
| 2 | Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine显示文摘AIM: To investigate the reduction in hepatitis B virus(HBV) covalently closed-circular DNA(ccc DNA) with entecavir(ETV) or lamivudine(LAM). METHODS: This analysis included patients who had participated in the randomized Phase Ⅲ study ETV-022 comparing ETV vs LAM in nucleos(t)ide-naive, HBe Agpositive patients. Patients received ETV(0.5 mg daily) or LAM(100 mg daily) for a minimum of 52 wk. Patients were eligible to participate in this sub-study if they had paired biopsies at baseline and week 48 with evaluable measurements for hepatic HBV ccc DNA and total hepatic HBV DNA. The main objective was to compare changes in hepatic HBV ccc DNA and total hepatic HBV DNA at week 48 of ETV or LAM treatment, which was a secondary endpoint of study ETV-022. Additional post hoc analyses included linear regression analyses to assess associations of baseline levels and on-treatment changes of ccc DNA with other baseline factors [sex,age, serum HBV DNA, alanine aminotransferase(ALT), Knodell necroinflammatory score, Ishak fibrosis score, total hepatic HBV DNA, and HBV genotype], or ontreatment factors(changes from baseline at week 48 in serum HBV DNA, ALT, Knodell necroinflammatory score, Ishak fibrosis score, total hepatic HBV DNA, and HBe Ag loss at week 48).RESULTS: Overall, 305 patients(ETV = 159; LAM = 146) of ETV-022 had paired baseline and week 48 liver biopsies with evaluable measurements for hepatic HBV ccc DNA and total hepatic HBV DNA, and were included in this analysis. Baseline demographics and disease characteristics were comparable between the two arms. After 48 wk, ETV resulted in significantly greater reductions in hepatic HBV ccc DNA [-0.9 log10 copies/human genome equivalent(HGEq) vs-0.7 log10 copies/HGEq; P = 0.0033] and total hepatic DNA levels(-2.1 log10 copies/HGEq vs-1.6 log10 copies/HGEq; P < 0.0001) than LAM. Virologic, biochemical, and histologic response rates at week 48 were also greater with ETV than with LAM. Baseline HBV ccc DNA levels were positively associated with baseline levels of serum HBV DNA and total hepatic HBV DNA, and negatively associated with HBV genotype F. On-treatment changes in HBV ccc DNA levels were negatively associated with baseline levels of serum HBV DNA and baseline ALT, and were positively associated with on-treatment changes in the levels of serum HBV DNA, total hepatic HBV DNA levels, and ALT, change in Knodell necroinflammatory score, and HBe Ag loss.CONCLUSION: Forty-eight weeks of ETV resulted in greater reductions in ccc DNA and total hepatic HBV DNA than LAM, but long-term therapy may be needed for ccc DNA elimination. | Scott Bowden Stephen Locarnini Ting-Tsung Chang You-Chen Chao Kwang-Hyub Han Robert G Gish Robert A de Man Miao Yu Cyril Llamoso Hong Tang | 2015 | World Journal of Gastroenterology2015，21，15： | 11 |
| 3 | 再生型木塑复合材料的研究显示文摘为了充分利用城市固体废弃物中的各项资源,本项工作将固体废弃物中的高密度聚乙烯(H igh dens itypo lyethy lene,HDPE)回收后与废弃的木纤维进行复合,成功地制备出再生型木塑复合材料。研究了木纤维长度、含量以及相容剂对木塑复合材料热性能和力学性能的影响。通过扫描电子显微镜观察了复合材料的冲击断口形貌,分析了此类复合材料的断裂机制。结果表明:木纤维的加入使HDPE的结晶温度降低,结晶速度减慢;相容剂的加入大大改善了木纤维与基体树脂之间的界面结合。随着木纤维含量的增加,木塑复合材料的弯曲强度升高,冲击强度下降。 | 崔益华 Noruziaan Bahman Lee Stephen Chang Moe 陶杰 | 2005 | 南京航空航天大学学报2005，37，5： | 11 |
| 4 | 混杂型高模量高韧性复合材料加强筋显示文摘针对现有复合材料加强筋存在的弹性模量低、断裂延伸率小、成本高等问题,以成本低廉的钢纤维作为主要增强材料,建立了一种新型混杂型复合材料加强筋的理论模型。分别制备了玻璃纤维复合材料加强筋和新型混杂型复合材料加强筋试样,测试并分析了其单轴拉伸行为,并进行了加速腐蚀试验。结果表明:这种新型混杂型复合材料加强筋的弹性模量达142 GPa,与玻璃纤维复合材料加强筋相比,具有耐腐蚀、韧性好、成本低的特点。 | 崔益华 NORUZIAAN Bahman LEE Stephen CHANG Moe 陶杰 | 2006 | 复合材料学报2006，23，2： | 10 |
| 5 | Therapeutic advances: Single incision laparoscopic hepatopancreatobiliary surgery显示文摘Single-port laparoscopic surgery(SPLS) is proposed to be a step towards minimizing the invasiveness of surgery, and has since gained popularity in several surgical sub-specialties including hepatopancreatobiliary surgery. SPLS has since been applied to cholecystectomy, liver resection as well as pancreatectomy for a multitude of pathologies. Benefits of SPLS over conventional multi-incision laparoscopic surgery include improved cosmesis and potentially post-operative pain at specific time periods and extra-umbilical sites. However, it is also associated with longer operating time, increased rate of complications, and increased rate of port-site hernia. There is no significant difference between length of hospital stay. SPLS has a significant learning curve that affects operating time, rate of conversion and rate of complications. In this article, we review the literature on SPLS in hepatobiliary surgery- cholecystectomy, hepatectomy and pancreatectomy, and offer tips on overcoming potential technical obstacles and minimizing the complications when performing SPLS- surgeon position, position of port and instruments, instrument crossing position, standard hand grip vs reverse hand grip, snooker cue guide position, prevention of incisional hernia. SPLS is a promising direction in laparoscopic surgery, and we recommend step-wise progression of applications of SPLS to various hepatopancreatobiliary surgeries to ensure safe adoption of the surgical technique. | Stephen Kin Yong Chang Kai Yin Lee | 2014 | World Journal of Gastroenterology2014，20，39： | 8 |
| 6 | SBS改性再生型木塑复合材料及其耐水性能显示文摘为了充分利用城市固体废弃物中的各项资源,本项工作将固体废弃物中的高密度聚乙烯(HDPE)回收后与废弃的木纤维、苯乙烯-丁二烯-苯乙烯(SBS)进行复合,成功地制备出SBS/再生型木塑复合材料,并进行了力学性能测试和水煮试验。结果表明,SBS的加入使木塑复合材料的冲击韧性得到显著改善,同时,复合材料的弯曲强度和弯曲模量没有明显的影响,表明SBS可以作为木塑复合材料的增韧剂。SBS/木塑复合材料经过8周、60℃的水煮后,复合材料的吸水率和厚度膨胀率均有所增加,弯曲模量和冲击韧性分别平均下降14.4%、10.8%。水煮试验初期复合材料的弯曲强度逐渐降低,然后又逐渐增大,第8周后弯曲强度增加的幅度约10%。木塑复合材料的冲击破坏模式以界面脱粘为主,而加入SBS后,复合材料的破坏以纤维断裂和基体断裂为主。 | 崔益华 Noruziaan Bahman Lee Stephen Chang Moe 陶杰 | 2006 | 宇航材料工艺2006，36，4： | 7 |
| 7 | Comparative study and systematic review of laparoscopic liver resection for hepatocellular carcinoma显示文摘AIM: To compare the surgical outcomes between laparoscopic liver resection(LLR) and open liver resection(OLR) as a curative treatment in patients with hepatocellular carcinoma(HCC). METHODS: A Pub Med database search was performed systematically to identify comparative studies of LLR vs OLR for HCC from 2000 to 2014. An extensive text word search was conducted, using combinations of search headings such as 'laparoscopy', 'hepatectomy', and 'hepatocellular carcinoma'. A comparative study was also performed in our institution where we analysed surgical outcomes of 152 patients who underwent liver resection between January 2005 to December 2012, of which 42 underwent laparoscopic or hand-assisted laparoscopic resection and 110 underwent open resection. RESULTS: Analysis of our own series and a review of 17 high-quality studies showed that LLR was superior to OLR in terms of short-term outcomes, as patients in the laparoscopic arm were found to have less intraoperative blood loss, less blood transfusions, and a shorter length of hospital stay. In our own series, both LLR and OLR groups were found to have similar overall survival(OS) rates, but disease-free survival(DFS) rates were higher in the laparoscopic arm. CONCLUSION: LLR is associated with better short-term outcomes compared to OLR as a curative treatment for HCC. Long-term oncologic outcomes with regards to OS and DFS rates were found to be comparable in both groups. LLR is hence a safe and viable option for curative resection of HCC. | Wei Qi Leong Iyer Shridhar Ganpathi Alfred Wei Chieh Kow Krishnakumar Madhavan Stephen Kin Yong Chang | 2015 | World Journal of Hepatology2015，7，27： | 7 |
| 8 | Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique显示文摘 | Arvil D. Stephens MD Robert Alderman PA-C David Chang MD Gary D. Edwards PA-C Jesus Esquivel MD Gilbert Sebbag MD Mark A. Steves MD Paul H. Sugarbaker MD | 1999 | Annals of Surgical Oncology1999，，8： | 5 |
| 9 | 159例腹腔镜根治性前列腺癌切除术的疗效评估显示文摘目的探讨腹腔镜根治性前列腺切除术的疗效.方法回顾性分析2000年3月至2003年8月159例腹腔镜根治性前列腺切除术患者资料.平均年龄58岁(42~74岁),同时行双侧盆腔淋巴结清扫术57例(35.9%).术前159例患者前列腺活检均确诊为前列腺癌.Gleason肿瘤分级:3+3:129例(81.1%),3+4:23例(14.5%),4+3:4例(2.5%),4+4:3例(1.9%).TNM肿瘤分期:T1c126例(79.3%),T2a 33例(20.7%).结果 159例患者平均手术时间298 min(165~660min).术中估计失血量平均293 ml(50~2500 ml),发生严重并发症15例(9.4%),其中中转开放手术6例(3.8%),无死亡病例.术后病理确诊为前列腺癌158例,1例诊断为良性前列腺增生伴急性前列腺炎.标本切缘阳性34例(21.5%).术后1年53例患者获得随访,术前31例(58.5%)有阴茎勃起功能的患者根据国际阴茎勃起功能指数(ⅡEF-5)评分分组进行术后变化评估.术后ⅡEF-5评分显著下降,各评分组间的差异无统计学意义.36例(67.9%)可通过使用Viagra等药物进行性生活,6例(11.3%)有尿失禁.结论腹腔镜根治性前列腺切除术是一种相对安全、微创、并发症低、术后康复快,同时又能达到肿瘤治疗效果的手术方法.但长期疗效尚待进一步观察. | 李爱华 Demetrius H.Bagley Edouard Trabulsi Deborah T.Glassman Stephen Strup Mark Chang Dolores Shupp-Byrne Leonard G.Gomella | 2005 | 中华泌尿外科杂志2005，26，12： | 4 |
| 10 | Percutaneous paraumbilical embolization as an unconventional and successful treatment for bleeding jejunal varices显示文摘A 48-year-old Indian male with alcoholic liver cirrhosis was admitted after being found unresponsive. He was hypotensive and had hematochezia. Esophagogastroduodenoscopy (EGD) showed small esophageal varices and a clean-based duodenal ulcer. He continued to have hematochezia and anemia despite blood transfusions. Colonoscopy was normal. Repeat EGD did not reveal any source of recent bleed. Twelve days after admission, his hematochezia ceased. He refused further investigation and was discharged two days later. He presented one week after discharge with hematochezia. EGD showed non-bleeding Grade 1 esophageal varices and a clean-based duodenal ulcer. Colonoscopy was normal. Abdominal computed tomography (CT) showed liver cirrhosis with mild ascites, paraumbilical varices, and splenomegaly. He had multiple episodes of hematochezia, requiring repeated blood transfusions. Capsule endoscopy identified the bleeding site in the jejunum. Concurrently, CT angiography showed paraumbilical varices inseparable from a loop of small bowel, which had herniated through an umbilical hernia. The lumen of this loop of small bowel opacified in the delayed phase, which suggested variceal bleeding into the small bowel. Portal vein thrombosis was present. As he had severe coagulopathy and extensive paraumbilical varices, surgery was of high risk. He was not suitable for transjugular intrahepatic porto-systemic shunt as he had portal vein thrombosis. Percutaneous paraumbilical embolization via caput medusa was performed on day 9 of hospitalization. Following the embolization, the hematochezia stopped. However, he defaulted subsequent follow-up. | Lee-Guan Lim Yin-Mei Lee Lenny Tan Stephen Chang Seng-Gee Lim | 2009 | World Journal of Gastroenterology2009，15，30： | 4 |
| 11 | Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance显示文摘 | James A. McCubrey Linda S. Steelman William H. Chappell Stephen L. Abrams Ellis W.T. Wong Fumin Chang Brian Lehmann David M. Terrian Michele Milella Agostino Tafuri Franca Stivala Massimo Libra Jorg Basecke Camilla Evangelisti Alberto M. Martelli Richard | 2006 | BBA - Molecular Cell Research2006，，8： | 3 |
| 12 | Enhanced photocurrent and photoluminescence spectra in MoS2 under ionic liquid gating显示文摘 | Zhen Li Shun-Wen Chang Chun-Chung Chen Stephen B. Cronin | 2014 | Nano Research2014，7，7： | 2 |
| 13 | Neo- and Paleopolyploidy contribute to the species diversity of Asplenium the most species-rich genus of ferns显示文摘Polyploidy 广泛地在植物的进化被看作一个主要过程,但是多倍体种类差异的累积仍然是争论的。一些最近的研究与他们的双祖先相比在 neopolyploids 建议了增加的扑灭风险。多倍体蕨纲植物的高比例被期望主要被 neopolyploids 形成,而 paleopolyploid 种类被预言在整个染色体复制成立的 clades 被聚类。这里,我们由在导出的蕨纲植物家庭 Aspleniaceae 探索 polyploidy 的进化测试这预言。家庭有全球分布并且在所有蕨纲植物之中显示出多倍体 taxa 的最高的频率。测试假设,我们用代表 292 种类的 883 个标本的叶绿体 DNA 序列获得了全面发展史。所有出版染色体计数被印射到这个种系发生的框架上以便探索多倍体的进化。我们 Aspleniaceae 的历史上为几整个染色体复制恢复了证据。超过 tetraploid 水平的多倍体的种系发生的关系建议那 tetraploid Asplenium 种可能在这个家庭的某 clades 作为主要进化播放器代替了他们的双祖先。 | Harald Schneider Hong-Mei Liu Yan-Fen Chang Daniel Ohlsen Leon R. Perrie Lara Shepherd Michael Kessler Dirk N. Karger Sabine Hennequin Jeannine Marquardt Stephen Russell Stephen Ansell Ngan Thi Lu Peris Kamau Josmaily Loriga Ledis Regalado Jochen Heinrichs Atsushi Ebihara Alan R. Smith Mary Gibby | 2017 | Journal of Systematics and Evolution2017，55，4： | 2 |
| 14 | 手助式腹腔镜肾切除术围手术期并发症的处理显示文摘目的探讨手助式腹腔镜肾切除术围手术期并发症的处理方法。方法回顾性分析1998-2004年377例手助式腹腔镜肾切除术患者资料,其中根治性肾切除术206例,单纯性肾切除术91例,根治性肾、输尿管切除术49例,肾部分切除术31例,对围手术期并发症类型、发生率及处理方法进行统计分析。结果377例患者术中估计失血量平均315.6 ml(30~7000 m1)。术中发生脾脏损伤、难以控制的出血、肠道损伤、肾蒂血管损伤、胰腺损伤等并发症14例(3.7%)。中转开放手术13例(3.4%)。术后发生肠梗阻、肺炎、切口疝、继发性出血、冠心病发作、血管栓塞、低钠血症等并发症48例(12.7%)。死亡2例(0.5%)。有腹腔或腹膜后手术史者围手术期并发症和术式中转率高于无手术史者。结论手助式腹腔镜。肾切除术仍会出现一些严重的围手术期并发症。局部粘连、肿瘤体积过大会增加并发症的发生。术中一旦出现严重出血、器官损伤等难以控制的并发症时应及时中转开放手术。充分的术前准备、正确熟练的手术操作可降低并发症的发生率。 | 李爱华 Leonard G.Gomella Ramsay Kuo Dolores Shupp-Byrne Mark Chang Stephen Strup Demetrias H.Bagley | 2006 | 中华泌尿外科杂志2006，27，10： | 2 |
| 15 | Laparoendoscopic single-site minor hepatectomy for liver tumors显示文摘 | Ek Tan Victor Lee Stephen Chang Iyer Ganpathi Krishnakumar Madhavan Davide Lomanto | 2012 | Surgical Endoscopy2012，，7： | 2 |
| 16 | On-chip multiplexed single-cell patterning and controllable intracellular delivery显示文摘Conventional electroporation approaches show limitations in the delivery of macromolecules in vitro and in vivo.These limitations include low efficiency,noticeable cell damage and nonuniform delivery of cells.Here,we present a simple 3D electroporation platform that enables massively parallel single-cell manipulation and the intracellular delivery of macromolecules and small molecules.A pyramid pit micropore array chip was fabricated based on a silicon wet-etching method.A controllable vacuum system was adopted to trap a single cell on each micropore.Using this chip,safe single-cell electroporation was performed at low voltage.Cargoes of various sizes ranging from oligonucleotides(molecular beacons,22 bp)to plasmid DNA(CRISPR-Cas9 expression vectors,>9 kb)were delivered into targeted cells with a significantly higher transfection efficiency than that of multiple benchmark methods(e.g.,commercial electroporation devices and Lipofectamine).The delivered dose of the chemotherapeutic drug could be controlled by adjusting the applied voltage.By using CRISPR-Cas9 transfection with this system,the p62 gene and CXCR7 gene were knocked out in tumor cells,which effectively inhibited their cellular activity.Overall,this vacuum-assisted micropore array platform provides a simple,efficient,high-throughput intracellular delivery method that may facilitate on-chip cell manipulation,intracellular investigation and cancer therapy. | Zaizai Dong Yanli Jiao Bingteng Xie Yongcun Hao Pan Wang Yuanyuan Liu Junfeng Shi Chandani Chitrakar Stephen Black Yu-Chieh Wang LJames Lee Mo Li Yubo Fan Lingqian Chang | 2020 | Microsystems & Nanoengineering2020，6，1： | 2 |
| 17 | Biomarkers of Brain Injury in Neonatal Encephalopathy Treated with Hypothermia显示文摘 | An N. Massaro Taeun Chang Nadja Kadom Tammy Tsuchida Joseph Scafidi Penny Glass Robert McCarter Stephen Baumgart Gilbert Vezina Karin B. Nelson | 2012 | The Journal of Pediatrics2012，，3： | 2 |
| 18 | Biomarker-guided sequential targeted therapies to overcome therapy resistance in rapidly evolving highly aggressive mammary tumors显示文摘组合指向的治疗在由堵住治疗癌症是更有效的绕过机制或导致的合成致命性。然而,他们的临床的申请被抵抗和毒性妨碍。遇见这重要挑战,我们用 ErbB2-overexpressing/PTEN-low 开发了并且测试各种各样的指向的治疗的指导 biomarker 的顺序的应用程序的一个新奇概念,高度好攻击的乳癌作为我们的模型。惊人地,从遗传上设计的鼠标与 intratumoral 异质从病人和乳房的肿瘤在两 PTEN-low/trastuzumab-resistant 乳癌支撑了 ErbB2 和下游的小径驱动器 trastuzumab 抵抗的激活。尽管 lapatinib 开始禁止了 trastuzumab 抵抗的鼠标肿瘤,肿瘤由激活表明由量的蛋白质数组出现的网络的 PI3K/mTOR 绕过抑制。有趣地,小径也是的 mTOR 的激活在 neoadjuvant 观察了表明 lapatinib 抵抗的对待 lapatinib 的病人。Trastuzumab + lapatinib 抵抗被一个 PI3K/mTOR 双 kinase 禁止者(BEZ235 ) 的顺序的申请有效地没有重要毒性克服。然而,我们的 p-RTK 数组分析证明 BEZ235 治疗在遗传上设计的老鼠肿瘤导致了增加的 ErbB2 表示和 phosphorylation,导致 BEZ235 抵抗并且在 3-D,然而并非 2-D,文化。机械学地,我们作为 BEZ235 抵抗的新奇机制识别了 ErbB2 蛋白质稳定和激活,它被随后的治疗与 lapatinib + BEZ235 联合颠倒。显著地, biomarker 指导的指向的治疗的这个顺序的应用程序在很快发展加倍的抵抗的肿瘤改变忍受极其好攻击的肿瘤的鼠标的寿命。使用的这条根本上新奇的途径有效地在一个顺序的顺序罐头指向了治疗目标和改编在在治疗期间发展抵抗的癌症的发信号的网络。 | Ozgur Sahin Qingfei Wang Samuel W Brady Kenneth Ellis Hai Wang Chia-Chi Chang Qingling Zhang Preety Priya Rui Zhu Stephen T Wong Melissa D Landis William J Muller Francisco J Esteva Jenny Chang Dihua Yu | 2014 | Cell Research2014，24，5： | 2 |
| 19 | Management of facial nerve injury due to temporal trauma显示文摘 | Chang C Y J Stephen P C | 1999 | Am J Otol1999，20，： | 1 |
| 20 | Laparoscopic Liver Resection for Peripheral Hepatocellular Carcinoma in Patients With Chronic Liver Disease: Midterm Results and Perspectives显示文摘 | Daniel Cherqui Alexis Laurent Claude Tayar Stephen Chang Jeanne Tran Van Nhieu Jér?me Loriau Mehdi Karoui Christophe Duvoux Daniel Dhumeaux Pierre-Louis Fagniez | 2006 | Annals of Surgery2006，，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员